文献速递神经核医学肿瘤 PET/CT

双时间窗采集协议下18F-氟比他班PET无创示踪动力学分析的验证

Validation of Noninvasive Tracer Kinetic Analysis of 18F-Florbetaben PET Using a Dual-Time-Window Acquisition Protocol.
PubMed 文献 · J Nucl Med · 2017-11-24

本研究基于20例受试者(10例 probable 阿尔茨海默痴呆患者和10例健康志愿者),比较完整动力学分析所得BPND与SUVR及无创示踪动力学方法(简化参考组织模型和多线性参考组织模型2),并评估缩短或中断采集方案与完整采集(0-140分钟)结果的一致性。采用0-30分钟和120-140分钟双时间窗并适当插值缺失时间点的采集方案,在患者舒适度与定量准确性间取得最佳折中;模拟显示脑血流和示踪剂清除变化对多线性参考组织模型参数及SUVR影响有限。结论认为双窗无创动力学建模准确,大多数临床研究应用SUVR方法合适,若纵向研究追求最大定量准确性则推荐此无创双窗采集加动力学分析。

要点

  • 双时间窗(0-30和120-140分钟)采集结合插值,在患者舒适度与定量准确性间取得最佳折中。
  • 双窗与完整协议BPND高度一致:多线性参考组织模型2 R²=0.97,简化参考组织模型 R²=0.93。
  • 模拟显示脑血流和示踪剂清除变化对多线性参考组织模型参数及SUVR影响有限。

核心结论

  • 本研究证明双窗采集可对18F-氟比他班PET数据进行准确的无创动力学建模,在定量准确性、扫描时长和患者负担之间提供良好折中。
  • 脑血流和示踪剂清除变化对淀粉样蛋白负荷估计的影响较小。
  • 对于大多数临床研究应用,SUVR方法合适;对于追求最大定量准确性的纵向研究,推荐采用此无创双窗采集加动力学分析。

研究设计与样本

  • 使用20例受试者数据(10例 probable 阿尔茨海默痴呆患者和10例健康志愿者),将完整动力学分析所得不可置换结合电位(BPND)与SUVR及无创示踪动力学方法(简化参考组织模型和多线性参考组织模型2)进行比较。
  • 比较多种缩短或中断采集方案与完整采集(0-140分钟)的结果,并通过模拟评估脑血流和示踪剂清除变化对SUVR及无创动力学建模输出的影响。

主要发现

  • 采用0-30分钟和120-140分钟时间窗并适当插值缺失时间点的采集方案,在患者舒适度和定量准确性之间提供最佳折中。
  • 完整协议与双窗协议所得BPND高度一致:多线性参考组织模型2为BPND(双窗)=0.01+1.00·BPND(完整),R²=0.97;简化参考组织模型为BPND(双窗)=0.05+0.92·BPND(完整),R²=0.93。
  • 模拟显示脑血流和示踪剂清除变化对多线性参考组织模型参数及SUVR的影响有限。

关键数值与推荐

  • 双窗协议时间窗为0-30分钟和120-140分钟,并对缺失时间点进行适当插值。
  • 多线性参考组织模型2:BPND(双窗)=0.01+1.00·BPND(完整),R²=0.97。
  • 简化参考组织模型:BPND(双窗)=0.05+0.92·BPND(完整),R²=0.93。
  • 完整采集时长为0-140分钟。

临床怎么用

  • 对于大多数临床研究应用,SUVR方法合适。
  • 对于追求最大定量准确性的纵向研究,推荐采用无创双窗采集加动力学分析。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Accurate amyloid PET quantification is necessary for monitoring amyloid-β accumulation and response to therapy. Currently, most of the studies are analyzed using the static SUV ratio (SUVR) approach because of its simplicity. However, this approach may be influenced by changes in cerebral blood flow (CBF) or radiotracer clearance. Full tracer kinetic models require arterial blood sampling and dynamic image acquisition. The objectives of this work were, first, to validate a noninvasive kinetic modeling approach for 18F-florbetaben PET using an acquisition protocol with the best compromise between quantification accuracy and simplicity and, second, to assess the impact of CBF changes and radiotracer clearance on SUVRs and noninvasive kinetic modeling data in 18F-florbetaben PET. Methods: Using data from 20 subjects (10 patients with probable Alzheimer dementia and 10 healthy volunteers), the nondisplaceable binding potential (BPND) obtained from the full kinetic analysis was compared with the SUVR and with noninvasive tracer kinetic methods (simplified reference tissue model and multilinear reference tissue model 2). Various approaches using shortened or interrupted acquisitions were compared with the results of the full acquisition (0-140 min). Simulations were performed to assess the effect of CBF and radiotracer clearance changes on SUVRs and noninvasive kinetic modeling outputs. Results: An acquisition protocol using time windows of 0-30 and 120-140 min with appropriate interpolation of the missing time points provided the best compromise between patient comfort and quantification accuracy. Excellent agreement was found between BPND obtained using the full protocol and BPND obtained using the dual-window protocol (for multilinear reference tissue model 2, BPND [dual-window] = 0.01 + 1.00·BPND [full], R2 = 0.97; for simplified reference tissue model, BPND [dual-window] = 0.05 + 0.92·BPND [full], R2 = 0.93). Simulations showed a limited impact of CBF and radiotracer clearance changes on multilinear reference tissue model parameters and SUVR. Conclusion: This study demonstrated accurate noninvasive kinetic modeling of 18F-florbetaben PET data using a dual-window acquisition, thus providing a good compromise between quantification accuracy, scan duration, and patient burden. The influence of CBF and radiotracer clearance changes on amyloid-β load estimates was small. For most clinical research applications, the SUVR approach is appropriate. However, for longitudinal studies in which maximum quantification accuracy is desired, this noninvasive dual-window acquisition with kinetic analysis is recommended.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Bullich S, Barthel H, Koglin N, et al. Validation of Noninvasive Tracer Kinetic Analysis of 18F-Florbetaben PET Using a Dual-Time-Window Acquisition Protocol. J Nucl Med. 2017. PMID: 29175981. doi:10.2967/jnumed.117.200964

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。